Stories from the lab: Researchers discuss innovative treatments for cancers of the blood
First in a new series that spotlights medicines in development, researchers from Bristol Myers Squibb discuss the application of gene-modified cell therapies in treating blood cancers, including lymphoma and multiple myeloma. During the interview, Teri Foy, Ph.D. and Justine Dell’Aringa shared their optimism that gene-modified cell therapies like CAR-T cells will help address this area of significant unmet medical need.
